Search Results - "Vignali, Dario"
-
1
Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
Published in Nature immunology (01-11-2019)“…Although immunotherapeutics targeting the inhibitory receptors (IRs) CTLA-4, PD-1 or PD-L1 have made substantial clinical progress in cancer, a considerable…”
Get full text
Journal Article -
2
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Published in Immunity (Cambridge, Mass.) (17-05-2016)“…The immune system is guided by a series of checks and balances, a major component of which is a large array of co-stimulatory and co-inhibitory pathways that…”
Get full text
Journal Article -
3
Interferon-γ: teammate or opponent in the tumour microenvironment?
Published in Nature reviews. Immunology (01-03-2022)“…Cancer immunotherapy offers substantive benefit to patients with various tumour types, in some cases leading to complete tumour clearance. However, many…”
Get full text
Journal Article -
4
IL-12 family cytokines: immunological playmakers
Published in Nature immunology (01-08-2012)“…The interleukin 12 (IL-12) family is unique in having the only heterodimeric cytokines, including IL-12, IL-23, IL-27 and IL-35. This feature endows these…”
Get full text
Journal Article -
5
How regulatory T cells work
Published in Nature reviews. Immunology (01-07-2008)“…Key Points Regulatory T (T Reg ) cells are essential for maintaining peripheral tolerance, preventing autoimmunity and limiting chronic inflammatory diseases…”
Get full text
Journal Article -
6
T Cell Exhaustion
Published in Annual review of immunology (28-06-2024)“…T cell responses must be balanced to ensure adequate protection against malignant transformation and an array of pathogens while also limiting damage to…”
Get full text
Journal Article -
7
LAG-3 as the third checkpoint inhibitor
Published in Nature immunology (01-09-2023)“…Lymphocyte activation gene 3 (LAG-3) is an inhibitory receptor that is highly expressed by exhausted T cells. LAG-3 is a promising immunotherapeutic target,…”
Get full text
Journal Article -
8
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
Published in Immunity (Cambridge, Mass.) (14-01-2020)“…Head and neck squamous cell carcinoma (HNSCC) arises through exposure to environmental carcinogens or malignant transformation by human papillomavirus (HPV)…”
Get full text
Journal Article -
9
The plasticity and stability of regulatory T cells
Published in Nature reviews. Immunology (01-06-2013)“…In this Viewpoint article, several experts share their thoughts on the plasticity and stability of regulatory T cells, discussing the recent advances in our…”
Get full text
Journal Article -
10
LAG3 (CD223) as a cancer immunotherapy target
Published in Immunological reviews (01-03-2017)“…Summary Despite the impressive impact of CTLA4 and PD1‐PDL1‐targeted cancer immunotherapy, a large proportion of patients with many tumor types fail to…”
Get full text
Journal Article -
11
Targeting regulatory T cells in tumors
Published in The FEBS journal (01-07-2016)“…Regulatory T (Treg) cells play a crucial role in maintaining peripheral tolerance and preventing autoimmunity. However, they also represent a major barrier to…”
Get full text
Journal Article -
12
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Published in Nature (22-11-2007)“…Regulatory T (T(reg)) cells are a critical sub-population of CD4+ T cells that are essential for maintaining self tolerance and preventing autoimmunity, for…”
Get full text
Journal Article -
13
Metabolic support of tumour-infiltrating regulatory T cells by lactic acid
Published in Nature (London) (25-03-2021)“…Regulatory T (T reg ) cells, although vital for immune homeostasis, also represent a major barrier to anti-cancer immunity, as the tumour microenvironment…”
Get full text
Journal Article -
14
Type 1 diabetes: translating mechanistic observations into effective clinical outcomes
Published in Nature reviews. Immunology (01-04-2013)“…Key Points For more than 25 years, type 1 diabetes (T1D) has been recognized as an autoimmune disease. The mechanisms involve innate and adaptive immune…”
Get full text
Journal Article -
15
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Published in Cancer research (Chicago, Ill.) (15-02-2012)“…Inhibitory receptors on immune cells are pivotal regulators of immune escape in cancer. Among these inhibitory receptors, CTLA-4 (targeted clinically by…”
Get full text
Journal Article -
16
Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
Published in Nature immunology (01-06-2019)“…Regulatory T cells (T reg cells) maintain host self-tolerance but are a major barrier to effective cancer immunotherapy. T reg cells subvert beneficial…”
Get full text
Journal Article -
17
Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity
Published in Nature immunology (01-09-2020)“…Robust CD8 + T cell memory is essential for long-term protective immunity but is often compromised in cancer, where T cell exhaustion leads to loss of memory…”
Get full text
Journal Article -
18
Once a Treg, always a Treg?
Published in Immunological reviews (01-05-2014)“…Summary Regulatory T cells (Tregs) prevail as a specialized cell lineage that has a central role in the dominant control of immunological tolerance and…”
Get full text
Journal Article -
19
Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
Published in The Journal of immunology (1950) (15-11-2016)“…Regulatory T cells (Tregs) are critical regulators of peripheral immune tolerance. Treg insufficiency can lead to autoimmune disorders, including type 1…”
Get full text
Journal Article -
20
Interleukin-35 Limits Anti-Tumor Immunity
Published in Immunity (Cambridge, Mass.) (16-02-2016)“…Regulatory T (Treg) cells pose a major barrier to effective anti-tumor immunity. Although Treg cell depletion enhances tumor rejection, the ensuing autoimmune…”
Get full text
Journal Article